UniProt ID | STAT3_HUMAN | |
---|---|---|
UniProt AC | P40763 | |
Protein Name | Signal transducer and activator of transcription 3 {ECO:0000312|HGNC:HGNC:11364} | |
Gene Name | STAT3 {ECO:0000312|HGNC:HGNC:11364} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 770 | |
Subcellular Localization | Cytoplasm. Nucleus . Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is in | |
Protein Description | Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors. [PubMed: 10688651] | |
Protein Sequence | MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAQWNQLQQ ------CCCHHHHHH | 24.09 | 22223895 | |
12 | Phosphorylation | NQLQQLDTRYLEQLH HHHHHHHHHHHHHHH | 29.79 | 24043423 | |
14 | Phosphorylation | LQQLDTRYLEQLHQL HHHHHHHHHHHHHHH | 19.38 | 29496907 | |
22 | Phosphorylation | LEQLHQLYSDSFPME HHHHHHHHHCCCCHH | 12.12 | 29496907 | |
23 | Phosphorylation | EQLHQLYSDSFPMEL HHHHHHHHCCCCHHH | 35.06 | 24043423 | |
25 | Phosphorylation | LHQLYSDSFPMELRQ HHHHHHCCCCHHHHH | 25.88 | 24043423 | |
45 | Phosphorylation | IESQDWAYAASKESH HHCCCHHHHHCHHHC | 9.84 | 20090780 | |
49 | "N6,N6-dimethyllysine" | DWAYAASKESHATLV CHHHHHCHHHCHHHH | 59.52 | - | |
49 | Acetylation | DWAYAASKESHATLV CHHHHHCHHHCHHHH | 59.52 | 18611949 | |
49 | Methylation | DWAYAASKESHATLV CHHHHHCHHHCHHHH | 59.52 | - | |
68 | Phosphorylation | LGEIDQQYSRFLQES HHHHHHHHHHHHHHH | 9.00 | - | |
79 | Phosphorylation | LQESNVLYQHNLRRI HHHHCHHHHHHHHHH | 11.93 | 28796482 | |
87 | Ubiquitination | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | 21890473 | |
87 | Ubiquitination | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | - | |
87 | 2-Hydroxyisobutyrylation | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | - | |
87 | Acetylation | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | 18611949 | |
87 | Ubiquitination | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | 22817900 | |
87 (in isoform 1) | Ubiquitination | - | 32.93 | 21890473 | |
87 (in isoform 2) | Ubiquitination | - | 32.93 | 21890473 | |
97 | Ubiquitination | LQSRYLEKPMEIARI HHHCCCCCHHHHHHH | 47.25 | 21890473 | |
97 | Ubiquitination | LQSRYLEKPMEIARI HHHCCCCCHHHHHHH | 47.25 | - | |
97 | Ubiquitination | LQSRYLEKPMEIARI HHHCCCCCHHHHHHH | 47.25 | 22817900 | |
97 (in isoform 1) | Ubiquitination | - | 47.25 | 21890473 | |
97 (in isoform 2) | Ubiquitination | - | 47.25 | 21890473 | |
118 | Phosphorylation | EESRLLQTAATAAQQ HHHHHHHHHHHHHHH | 20.45 | 24043423 | |
121 | Phosphorylation | RLLQTAATAAQQGGQ HHHHHHHHHHHHCCC | 21.77 | 24043423 | |
133 | Phosphorylation | GGQANHPTAAVVTEK CCCCCCCCEEECCHH | 21.50 | 24043423 | |
138 | Phosphorylation | HPTAAVVTEKQQMLE CCCEEECCHHHHHHH | 30.76 | 24043423 | |
140 | 2-Hydroxyisobutyrylation | TAAVVTEKQQMLEQH CEEECCHHHHHHHHH | 36.14 | - | |
140 | Methylation | TAAVVTEKQQMLEQH CEEECCHHHHHHHHH | 36.14 | 21098664 | |
140 | Ubiquitination | TAAVVTEKQQMLEQH CEEECCHHHHHHHHH | 36.14 | 29967540 | |
143 | Sulfoxidation | VVTEKQQMLEQHLQD ECCHHHHHHHHHHHH | 4.05 | 30846556 | |
145 | Neddylation | TEKQQMLEQHLQDVR CHHHHHHHHHHHHHH | 30.52 | 32015554 | |
145 | Ubiquitination | TEKQQMLEQHLQDVR CHHHHHHHHHHHHHH | 30.52 | 33845483 | |
148 | Ubiquitination | QQMLEQHLQDVRKRV HHHHHHHHHHHHHHH | 4.67 | 33845483 | |
151 | Neddylation | LEQHLQDVRKRVQDL HHHHHHHHHHHHHHH | 5.11 | 32015554 | |
151 | Ubiquitination | LEQHLQDVRKRVQDL HHHHHHHHHHHHHHH | 5.11 | 33845483 | |
153 | Ubiquitination | QHLQDVRKRVQDLEQ HHHHHHHHHHHHHHH | 57.69 | 29967540 | |
154 | Ubiquitination | HLQDVRKRVQDLEQK HHHHHHHHHHHHHHH | 22.29 | 33845483 | |
161 | 2-Hydroxyisobutyrylation | RVQDLEQKMKVVENL HHHHHHHHHHHHHHC | 31.17 | - | |
161 | Acetylation | RVQDLEQKMKVVENL HHHHHHHHHHHHHHC | 31.17 | 27452117 | |
161 | Ubiquitination | RVQDLEQKMKVVENL HHHHHHHHHHHHHHC | 31.17 | 29967540 | |
163 | Ubiquitination | QDLEQKMKVVENLQD HHHHHHHHHHHHCHH | 50.60 | 29967540 | |
176 | Phosphorylation | QDDFDFNYKTLKSQG HHHCCCCHHHHHCCC | 12.82 | - | |
177 | Ubiquitination | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | 21890473 | |
177 | Ubiquitination | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | 21906983 | |
177 | Neddylation | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | 32015554 | |
177 | Sumoylation | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | - | |
177 | Ubiquitination | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | 21963094 | |
177 (in isoform 1) | Ubiquitination | - | 48.78 | 21890473 | |
177 (in isoform 2) | Ubiquitination | - | 48.78 | 21890473 | |
180 | Ubiquitination | DFNYKTLKSQGDMQD CCCHHHHHCCCCCCC | 46.06 | 21906983 | |
180 | Ubiquitination | DFNYKTLKSQGDMQD CCCHHHHHCCCCCCC | 46.06 | 21906983 | |
180 (in isoform 1) | Ubiquitination | - | 46.06 | 21890473 | |
180 (in isoform 2) | Ubiquitination | - | 46.06 | 21890473 | |
181 | Phosphorylation | FNYKTLKSQGDMQDL CCHHHHHCCCCCCCC | 42.37 | 29214152 | |
185 | Sulfoxidation | TLKSQGDMQDLNGNN HHHCCCCCCCCCCCC | 4.23 | 21406390 | |
194 | Phosphorylation | DLNGNNQSVTRQKMQ CCCCCCCHHHHHHHH | 27.81 | - | |
196 | Phosphorylation | NGNNQSVTRQKMQQL CCCCCHHHHHHHHHH | 32.40 | 30387612 | |
199 | Ubiquitination | NQSVTRQKMQQLEQM CCHHHHHHHHHHHHH | 35.07 | 21906983 | |
199 | Ubiquitination | NQSVTRQKMQQLEQM CCHHHHHHHHHHHHH | 35.07 | 22817900 | |
199 (in isoform 1) | Ubiquitination | - | 35.07 | 21890473 | |
199 (in isoform 2) | Ubiquitination | - | 35.07 | 21890473 | |
212 | Ubiquitination | QMLTALDQMRRSIVS HHHHHHHHHHHHHHH | 28.29 | 33845483 | |
218 | Ubiquitination | DQMRRSIVSELAGLL HHHHHHHHHHHHHHH | 3.71 | 33845483 | |
236 | Phosphorylation | EYVQKTLTDEELADW HHHHHHCCHHHHHHH | 46.74 | - | |
244 | Ubiquitination | DEELADWKRRQQIAC HHHHHHHHHHHCCEE | 37.95 | 21890473 | |
244 | Ubiquitination | DEELADWKRRQQIAC HHHHHHHHHHHCCEE | 37.95 | 21906983 | |
244 | Acetylation | DEELADWKRRQQIAC HHHHHHHHHHHCCEE | 37.95 | 26051181 | |
244 | Ubiquitination | DEELADWKRRQQIAC HHHHHHHHHHHCCEE | 37.95 | 23000965 | |
244 (in isoform 1) | Ubiquitination | - | 37.95 | 21890473 | |
244 (in isoform 2) | Ubiquitination | - | 37.95 | 21890473 | |
262 | Ubiquitination | PPNICLDRLENWITS CCCCHHHHHHHHHHH | 30.84 | 33845483 | |
268 | Ubiquitination | DRLENWITSLAESQL HHHHHHHHHHHHHHH | 14.87 | 33845483 | |
283 | Ubiquitination | QTRQQIKKLEELQQK HHHHHHHHHHHHHHH | 63.86 | 29967540 | |
286 | Ubiquitination | QQIKKLEELQQKVSY HHHHHHHHHHHHHHC | 63.42 | 33845483 | |
290 | Ubiquitination | KLEELQQKVSYKGDP HHHHHHHHHHCCCCC | 21.86 | 23000965 | |
292 | Ubiquitination | EELQQKVSYKGDPIV HHHHHHHHCCCCCHH | 28.32 | 33845483 | |
294 | Ubiquitination | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | 21890473 | |
294 | Ubiquitination | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | 21906983 | |
294 | 2-Hydroxyisobutyrylation | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | - | |
294 | Ubiquitination | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | 23000965 | |
294 (in isoform 1) | Ubiquitination | - | 49.70 | 21890473 | |
294 (in isoform 2) | Ubiquitination | - | 49.70 | 21890473 | |
318 | Ubiquitination | ELFRNLMKSAFVVER HHHHHHHHHCCEEEC | 41.62 | 23000965 | |
319 | Phosphorylation | LFRNLMKSAFVVERQ HHHHHHHHCCEEECC | 16.99 | 30257219 | |
348 | Ubiquitination | TGVQFTTKVRLLVKF CCCCEEEEEEEEEEC | 23.46 | 29967540 | |
363 | Ubiquitination | PELNYQLKIKVCIDK HHHCCEEEEEEEEEC | 25.59 | 29967540 | |
365 | Ubiquitination | LNYQLKIKVCIDKDS HCCEEEEEEEEECCC | 29.48 | 29967540 | |
370 | 2-Hydroxyisobutyrylation | KIKVCIDKDSGDVAA EEEEEEECCCCCEEH | 33.60 | - | |
370 | Acetylation | KIKVCIDKDSGDVAA EEEEEEECCCCCEEH | 33.60 | 23749302 | |
370 | Malonylation | KIKVCIDKDSGDVAA EEEEEEECCCCCEEH | 33.60 | 26320211 | |
370 | Ubiquitination | KIKVCIDKDSGDVAA EEEEEEECCCCCEEH | 33.60 | 29967540 | |
383 | Acetylation | AALRGSRKFNILGTN EHHCCCCCEEEECCC | 44.45 | 25953088 | |
383 | Malonylation | AALRGSRKFNILGTN EHHCCCCCEEEECCC | 44.45 | 26320211 | |
383 | Ubiquitination | AALRGSRKFNILGTN EHHCCCCCEEEECCC | 44.45 | 29967540 | |
399 | Phosphorylation | KVMNMEESNNGSLSA EEECHHHHCCCCCCE | 23.45 | 25332170 | |
409 | Acetylation | GSLSAEFKHLTLREQ CCCCEEEEEHHHCCC | 29.25 | 26051181 | |
409 | Ubiquitination | GSLSAEFKHLTLREQ CCCCEEEEEHHHCCC | 29.25 | - | |
412 | Phosphorylation | SAEFKHLTLREQRCG CEEEEEHHHCCCCCC | 24.40 | 22468782 | |
429 | Phosphorylation | GRANCDASLIVTEEL CCCCCCEEEEEECEE | 12.84 | 19835603 | |
433 | Phosphorylation | CDASLIVTEELHLIT CCEEEEEECEEEEEE | 19.42 | 22468782 | |
440 | Phosphorylation | TEELHLITFETEVYH ECEEEEEEEECCHHC | 23.06 | 19835603 | |
446 | Phosphorylation | ITFETEVYHQGLKID EEEECCHHCCCCEEE | 5.12 | 19835603 | |
451 | Sumoylation | EVYHQGLKIDLETHS CHHCCCCEEECCCCC | 40.78 | - | |
451 | Sumoylation | EVYHQGLKIDLETHS CHHCCCCEEECCCCC | 40.78 | - | |
495 | Sumoylation | KNVNFFTKPPIGTWD CCCCCCCCCCCCCHH | 43.57 | - | |
539 | Phosphorylation | LLGPGVNYSGCQITW HHCCCCCCCCCEEEE | 12.20 | 21945579 | |
540 | Phosphorylation | LGPGVNYSGCQITWA HCCCCCCCCCEEEEH | 28.08 | 21945579 | |
545 | Phosphorylation | NYSGCQITWAKFCKE CCCCCEEEEHHHHHH | 8.09 | 21945579 | |
548 | Acetylation | GCQITWAKFCKENMA CCEEEEHHHHHHHCC | 42.74 | 26051181 | |
551 | Ubiquitination | ITWAKFCKENMAGKG EEEHHHHHHHCCCCC | 56.08 | 29967540 | |
573 | Ubiquitination | DNIIDLVKKYILALW HHHHHHHHHHHHHHH | 47.35 | 22817900 | |
574 | Ubiquitination | NIIDLVKKYILALWN HHHHHHHHHHHHHHH | 30.00 | 21906983 | |
574 | Ubiquitination | NIIDLVKKYILALWN HHHHHHHHHHHHHHH | 30.00 | 22817900 | |
574 (in isoform 1) | Ubiquitination | - | 30.00 | 21890473 | |
574 (in isoform 2) | Ubiquitination | - | 30.00 | 21890473 | |
594 | Ubiquitination | GFISKERERAILSTK EEECHHHHHHHHCCC | 47.78 | 33845483 | |
598 | Ubiquitination | KERERAILSTKPPGT HHHHHHHHCCCCCCE | 5.33 | 33845483 | |
599 | Phosphorylation | ERERAILSTKPPGTF HHHHHHHCCCCCCEE | 28.42 | 24719451 | |
600 | Ubiquitination | RERAILSTKPPGTFL HHHHHHCCCCCCEEE | 44.09 | 33845483 | |
601 | Acetylation | ERAILSTKPPGTFLL HHHHHCCCCCCEEEE | 45.93 | 28065600 | |
601 | Deamination | ERAILSTKPPGTFLL HHHHHCCCCCCEEEE | 45.93 | 28065600 | |
601 | Ubiquitination | ERAILSTKPPGTFLL HHHHHCCCCCCEEEE | 45.93 | 24816145 | |
605 | Phosphorylation | LSTKPPGTFLLRFSE HCCCCCCEEEEEEEC | 19.51 | - | |
606 | Ubiquitination | STKPPGTFLLRFSES CCCCCCEEEEEEECC | 8.19 | 33845483 | |
615 | Acetylation | LRFSESSKEGGVTFT EEEECCCCCCCEEEE | 70.43 | 28065600 | |
615 | Deamination | LRFSESSKEGGVTFT EEEECCCCCCCEEEE | 70.43 | 28065600 | |
615 | Ubiquitination | LRFSESSKEGGVTFT EEEECCCCCCCEEEE | 70.43 | 28065600 | |
617 | Ubiquitination | FSESSKEGGVTFTWV EECCCCCCCEEEEEE | 39.34 | 33845483 | |
619 | Ubiquitination | ESSKEGGVTFTWVEK CCCCCCCEEEEEEEE | 6.14 | 33845483 | |
626 | Ubiquitination | VTFTWVEKDISGKTQ EEEEEEEECCCCCEE | 51.23 | 22817900 | |
631 | Ubiquitination | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 21906983 | |
631 | Acetylation | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 28065600 | |
631 | Deamination | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 28065600 | |
631 | Ubiquitination | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 28065600 | |
631 (in isoform 1) | Ubiquitination | - | 30.39 | 21890473 | |
631 (in isoform 2) | Ubiquitination | - | 30.39 | 21890473 | |
632 | Phosphorylation | EKDISGKTQIQSVEP EECCCCCEEEEECCC | 34.14 | - | |
636 | Phosphorylation | SGKTQIQSVEPYTKQ CCCEEEEECCCCCHH | 30.03 | - | |
640 | Phosphorylation | QIQSVEPYTKQQLNN EEEECCCCCHHHHHC | 17.05 | - | |
641 | Phosphorylation | IQSVEPYTKQQLNNM EEECCCCCHHHHHCC | 32.85 | - | |
642 | Ubiquitination | QSVEPYTKQQLNNMS EECCCCCHHHHHCCC | 30.15 | 21963094 | |
657 | Phosphorylation | FAEIIMGYKIMDATN HHHHHHCCCCHHHCC | 4.67 | 15037656 | |
674 | Phosphorylation | VSPLVYLYPDIPKEE CCCHHHHCCCCCHHH | 4.91 | 22817900 | |
679 | Acetylation | YLYPDIPKEEAFGKY HHCCCCCHHHHCCCC | 69.40 | 19295512 | |
679 | Ubiquitination | YLYPDIPKEEAFGKY HHCCCCCHHHHCCCC | 69.40 | 32015554 | |
681 | Ubiquitination | YPDIPKEEAFGKYCR CCCCCHHHHCCCCCC | 56.26 | 32015554 | |
685 | Acetylation | PKEEAFGKYCRPESQ CHHHHCCCCCCHHHC | 34.42 | 28065600 | |
685 | Deamination | PKEEAFGKYCRPESQ CHHHHCCCCCCHHHC | 34.42 | 28065600 | |
685 | Ubiquitination | PKEEAFGKYCRPESQ CHHHHCCCCCCHHHC | 34.42 | 28065600 | |
686 | Phosphorylation | KEEAFGKYCRPESQE HHHHCCCCCCHHHCC | 8.28 | 21945579 | |
686 (in isoform 2) | Phosphorylation | - | 8.28 | 30108239 | |
687 | Ubiquitination | EEAFGKYCRPESQEH HHHCCCCCCHHHCCC | 7.15 | 32015554 | |
691 | Phosphorylation | GKYCRPESQEHPEAD CCCCCHHHCCCCCCC | 43.48 | 21945579 | |
691 (in isoform 2) | Phosphorylation | - | 43.48 | 30108239 | |
694 | Phosphorylation | CRPESQEHPEADPGS CCHHHCCCCCCCCCC | 20.19 | 32142685 | |
698 | Ubiquitination | SQEHPEADPGSAAPY HCCCCCCCCCCCCCC | 46.56 | 32015554 | |
699 | Phosphorylation | QEHPEADPGSAAPYL CCCCCCCCCCCCCCC | 45.76 | 32142685 | |
700 | Ubiquitination | EHPEADPGSAAPYLK CCCCCCCCCCCCCCC | 30.39 | 32015554 | |
701 | Phosphorylation | HPEADPGSAAPYLKT CCCCCCCCCCCCCCE | 27.01 | 21945579 | |
704 (in isoform 2) | Phosphorylation | - | 34.40 | 27273156 | |
705 | Phosphorylation | DPGSAAPYLKTKFIC CCCCCCCCCCEEEEE | 18.99 | 21918175 | |
705 (in isoform 3) | Phosphorylation | - | 18.99 | 25159151 | |
706 | Ubiquitination | PGSAAPYLKTKFICV CCCCCCCCCEEEEEE | 5.74 | 22817900 | |
707 | Acetylation | GSAAPYLKTKFICVT CCCCCCCCEEEEEEC | 43.77 | 28065600 | |
707 | Phosphorylation | GSAAPYLKTKFICVT CCCCCCCCEEEEEEC | 43.77 | 32142685 | |
707 | Ubiquitination | GSAAPYLKTKFICVT CCCCCCCCEEEEEEC | 43.77 | 21963094 | |
707 (in isoform 2) | Phosphorylation | - | 43.77 | 28152594 | |
708 | Phosphorylation | SAAPYLKTKFICVTP CCCCCCCEEEEEECC | 28.70 | 23401153 | |
708 | Ubiquitination | SAAPYLKTKFICVTP CCCCCCCEEEEEECC | 28.70 | 22817900 | |
709 | Acetylation | AAPYLKTKFICVTPT CCCCCCEEEEEECCC | 31.01 | 19295512 | |
709 | Ubiquitination | AAPYLKTKFICVTPT CCCCCCEEEEEECCC | 31.01 | 22817900 | |
712 | Ubiquitination | YLKTKFICVTPTTCS CCCEEEEEECCCCCC | 2.91 | 32015554 | |
713 (in isoform 2) | Phosphorylation | - | 6.50 | 29116813 | |
714 | O-linked_Glycosylation | KTKFICVTPTTCSNT CEEEEEECCCCCCCC | 15.54 | 30059200 | |
714 | Phosphorylation | KTKFICVTPTTCSNT CEEEEEECCCCCCCC | 15.54 | 22322096 | |
715 (in isoform 2) | Phosphorylation | - | 12.81 | 25159151 | |
716 | O-linked_Glycosylation | KFICVTPTTCSNTID EEEEECCCCCCCCCC | 30.94 | 30059200 | |
716 | Phosphorylation | KFICVTPTTCSNTID EEEEECCCCCCCCCC | 30.94 | 30266825 | |
717 | O-linked_Glycosylation | FICVTPTTCSNTIDL EEEECCCCCCCCCCC | 18.36 | 30059200 | |
717 | Phosphorylation | FICVTPTTCSNTIDL EEEECCCCCCCCCCC | 18.36 | 30266825 | |
718 | Phosphorylation | ICVTPTTCSNTIDLP EEECCCCCCCCCCCC | 3.04 | 32142685 | |
719 | O-linked_Glycosylation | CVTPTTCSNTIDLPM EECCCCCCCCCCCCC | 34.61 | 30059200 | |
719 | Phosphorylation | CVTPTTCSNTIDLPM EECCCCCCCCCCCCC | 34.61 | 30266825 | |
720 | Phosphorylation | VTPTTCSNTIDLPMS ECCCCCCCCCCCCCC | 43.11 | 32142685 | |
721 | O-linked_Glycosylation | TPTTCSNTIDLPMSP CCCCCCCCCCCCCCH | 10.28 | 30059200 | |
721 | Phosphorylation | TPTTCSNTIDLPMSP CCCCCCCCCCCCCCH | 10.28 | 30266825 | |
723 | Phosphorylation | TTCSNTIDLPMSPRT CCCCCCCCCCCCHHH | 42.56 | 32142685 | |
726 | Phosphorylation | SNTIDLPMSPRTLDS CCCCCCCCCHHHHHH | 12.84 | 32142685 | |
727 | O-linked_Glycosylation | NTIDLPMSPRTLDSL CCCCCCCCHHHHHHH | 14.86 | 30059200 | |
727 | Phosphorylation | NTIDLPMSPRTLDSL CCCCCCCCHHHHHHH | 14.86 | 22322096 | |
730 | Phosphorylation | DLPMSPRTLDSLMQF CCCCCHHHHHHHHHC | 38.00 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
45 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
68 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
640 | Y | Phosphorylation | Kinase | TYK2 | P29597 | PSP |
705 | Y | Phosphorylation | Kinase | PKM | P14618 | PSP |
705 | Y | Phosphorylation | Kinase | AXL | P30530 | PSP |
705 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
705 | Y | Phosphorylation | Kinase | RET ISO3 | Q15300 | PSP |
705 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | Uniprot |
705 | Y | Phosphorylation | Kinase | NEK6 | Q9HC98 | PSP |
705 | Y | Phosphorylation | Kinase | MERTK | Q12866 | GPS |
705 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | PSP |
705 | Y | Phosphorylation | Kinase | JAK2 | O60674 | PSP |
705 | Y | Phosphorylation | Kinase | FER | P16591 | Uniprot |
705 | Y | Phosphorylation | Kinase | FER | P70451 | PSP |
705 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
714 | T | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
714 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
727 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
727 | S | Phosphorylation | Kinase | CDK1 | P06493 | GPS |
727 | S | Phosphorylation | Kinase | CDK2 | P24941 | GPS |
727 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
727 | S | Phosphorylation | Kinase | DAPK3 | O43293 | Uniprot |
727 | S | Phosphorylation | Kinase | DYRK2 | Q92630 | Uniprot |
727 | S | Phosphorylation | Kinase | NLK | Q9UBE8 | Uniprot |
727 | S | Phosphorylation | Kinase | NEK6 | Q9HC98 | Uniprot |
727 | S | Phosphorylation | Kinase | MTOR | Q9JLN9 | PSP |
727 | S | Phosphorylation | Kinase | MAPK9 | P45984-2 | GPS |
727 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
727 | S | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
727 | S | Phosphorylation | Kinase | RPS6KA5 | O75582 | Uniprot |
727 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
727 | S | Phosphorylation | Kinase | PKCE | Q02156 | PSP |
727 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
727 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
727 | S | Phosphorylation | Kinase | IRAK1 | P51617 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | COP1 | Q8NHY2 | PMID:27820701 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
727 | S | Phosphorylation |
| 12763138 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STAT3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
147060 | Hyperimmunoglobulin E recurrent infection syndrome, autosomal dominant (AD-HIES) | |||||
615952 | Autoimmune disease, multisystem, infantile-onset (ADMIO) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-714 AND SER-727, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-714 AND SER-727, ANDMASS SPECTROMETRY. | |
"BART is essential for nuclear retention of STAT3."; Muromoto R., Sekine Y., Imoto S., Ikeda O., Okayama T., Sato N.,Matsuda T.; Int. Immunol. 20:395-403(2008). Cited for: INTERACTION WITH ARL2BP, PHOSPHORYLATION AT SERINE RESIDUES, ANDSUBCELLULAR LOCATION. | |
"Role for DYRK family kinases on regulation of apoptosis."; Yoshida K.; Biochem. Pharmacol. 76:1389-1394(2008). Cited for: PHOSPHORYLATION AT SER-727 BY DYRK2. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
"Protein kinase Cepsilon interacts with signal transducers andactivators of transcription 3 (Stat3), phosphorylates Stat3Ser727, andregulates its constitutive activation in prostate cancer."; Aziz M.H., Manoharan H.T., Church D.R., Dreckschmidt N.E., Zhong W.,Oberley T.D., Wilding G., Verma A.K.; Cancer Res. 67:8828-8838(2007). Cited for: INTERACTION WITH PRKCE, AND PHOSPHORYLATION AT SER-727. | |
"Physical and functional interactions between STAT3 and ZIP kinase."; Sato N., Kawai T., Sugiyama K., Muromoto R., Imoto S., Sekine Y.,Ishida M., Akira S., Matsuda T.; Int. Immunol. 17:1543-1552(2005). Cited for: PHOSPHORYLATION AT SER-727 BY ZIPK/DAPK3, INTERACTION WITH ZIPK/DAPK3,AND SUBCELLULAR LOCATION. | |
"IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression."; Huang Y., Li T., Sane D.C., Li L.; J. Biol. Chem. 279:51697-51703(2004). Cited for: PHOSPHORYLATION AT SER-727 BY IRAK1. | |
"Erythropoietin-induced serine 727 phosphorylation of STAT3 inerythroid cells is mediated by a MEK-, ERK-, and MSK1-dependentpathway."; Wierenga A.T., Vogelzang I., Eggen B.J., Vellenga E.; Exp. Hematol. 31:398-405(2003). Cited for: PHOSPHORYLATION AT TYR-705 AND SER-727. | |
"Requirement of serine phosphorylation for formation of STAT-promotercomplexes."; Zhang X., Blenis J., Li H.-C., Schindler C., Chen-Kiang S.; Science 267:1990-1994(1995). Cited for: PHOSPHORYLATION AT SERINE RESIDUES. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-539 AND TYR-705, ANDMASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASSSPECTROMETRY. | |
"Identification of STAT3 as a specific substrate of breast tumorkinase."; Liu L., Gao Y., Qiu H., Miller W.T., Poli V., Reich N.C.; Oncogene 25:4904-4912(2006). Cited for: PHOSPHORYLATION AT TYR-705 BY PTK6. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASSSPECTROMETRY. |